Predict your next investment

HEALTHCARE | Biotechnology
cytosolix.com

See what CB Insights has to offer

Stage

Convertible Note | Alive

Total Raised

$230K

Last Raised

$230K | 2 yrs ago

About Cytosolix

Developer of a small-molecule tumor targeted chemotherapy platform.

Cytosolix Headquarter Location

97 Robbie Road

Tolland, Connecticut, 06084,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cytosolix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cytosolix is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.